Taiwan: Chang Gung Hospital_multinational trial_the heart side effect on herceptin-treated breast cancer patients

J Clin Oncol. 2010 Jun 7.
Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial.
Even the low incidence rate of cardiac disorder (5.1%) after long term herceptin treatment, it appears higher than control subjects. http://www.ncbi.nlm.nih.gov/pubmed/20530280